Bleeding risk of rivaroxaban and edoxaban with and without amiodarone in atrial fibrillation patients: a prospective cohort study

European Journal of Clinical Pharmacology 2026

View at publisher

Authors: Zi Wang, Fan Yang, Qiming Wang, Xin Xia, Qianzhou Lv

DOI: 10.1007/s00228-026-04004-y

Cited by: 1

References: 31

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Venous Thromboembolism Diagnosis and Management Acute Ischemic Stroke Management

References 31